About Aaron Missere

Aaron Missere is the CEO and founder of financial media company Departures Capital Inc. He is an avid and experienced investor, with a primary focus on the cannabis industry. In addition to being a featured contributor to StockNews.com and ETFDailyNews.com, he is an author for SmarterAnalyst.com. Aaron also currently hosts a weekly show on YouTube that recaps and explains the movement in the stock market, with a heavy emphasis on marijuana stocks.

Recent Articles By Aaron Missere

: CTST |  News, Ratings, and Charts

CannTrust (CTST) Loses its License, What Happens Next?

Just as we thought we were coming to a conclusion in terms of the CannTrust (CTST) scandal, things took another turn.
: IIPR |  News, Ratings, and Charts

Can Innovative Industrial Properties (IIPR) sustain their acquisition spree momentum?

This year has been an extremely eventful year for Innovative Industrial Properties, the first and only Cannabis REIT on the NYSE.
: ACB |  News, Ratings, and Charts

Why did shares of Aurora Cannabis (ACB) plunge 10% this week?

Aurora Cannabis is the most popular stock among millennials on the extremely popular Robinhood trading app.
: CTST |  News, Ratings, and Charts

Will CannTrust Holdings (CTST) be Delisted?

So what's next for CannTrust and when is this whole ordeal going to come to a head?
: VFF |  News, Ratings, and Charts

Does Village Farms (VFF) Remain a Buy?

Despite the volatility within the cannabis sector in the second half of 2019, Village Farms has maintained a pretty decent trajectory compared to some of its peers.
: CRON |  News, Ratings, and Charts

Is Cronos Group (CRON) a Buy right now?

We are taking a close look at Cronos group today to see if now is the time to buy the dip in shares of the company.
: ACB |  News, Ratings, and Charts

Will Aurora Cannabis (ACB) Surprise Investors this quarter?

This quarter will be a crucial quarter for Aurora Cannabis as many investors have high hopes for the company.
: IIPR |  News, Ratings, and Charts

Should you buy the pullback in Innovative Industrial Properties (IIPR)?

2019 has been a very exciting year for Innovative Industrial Properties REIT.
: TLRY |  News, Ratings, and Charts

Is it Finally Time to Buy Tilray (TLRY)?

It's safe to say that it has been a brutal summer for most cannabis stocks. We have seen a relentless selloff since the spring and prices continue to plunge.
: GWPH |  News, Ratings, and Charts

Should you buy the pullback in GW Pharmaceuticals (GWPH)?

GW Pharmaceuticals is a stock that we feel does not get enough attention when it comes to the CBD/Cannabis sector.
Page generated in 0.0051 seconds.